Turku, Finland

Riikka Lund


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal1 out of 832,812 
Other
 patents

Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Riikka Lund - Innovator in Immune-Mediated Disease Research

Introduction

Riikka Lund is a prominent inventor based in Turku, Finland. She has made significant contributions to the field of immunology, particularly in understanding immune-mediated diseases. Her innovative work has led to the development of methods that utilize novel target genes related to conditions such as asthma, allergies, and autoimmune diseases.

Latest Patents

Riikka Lund holds 1 patent for her invention titled "Methods utilizing target genes related to immune-mediated diseases." This invention provides methods that are based on a molecular level description of the polarization of CD4+ precursor cells, which are known to give rise to T helper cells. The patent outlines a method for identifying compounds capable of modulating the polarization of CD4+ lymphocytes. Additionally, it includes a method for assessing the presence of, or predisposition to, an immune-related disorder in a subject.

Career Highlights

Throughout her career, Riikka Lund has focused on advancing the understanding of immune-mediated diseases. Her research has been instrumental in identifying potential therapeutic targets that could lead to better treatment options for patients suffering from these conditions.

Collaborations

Riikka has collaborated with notable colleagues in her field, including Zhi David Chen and Riitta Lahesmaa. These collaborations have further enriched her research and contributed to the advancement of knowledge in immunology.

Conclusion

Riikka Lund's innovative work in the field of immune-mediated diseases showcases her dedication to improving health outcomes through scientific research. Her contributions are paving the way for future advancements in the treatment of these complex conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…